DEMONIC DEFIANCE

Defiant moms chug Tylenol in viral vids, mocking Trump, blind to autism risk study findings.

EVIL / VIDEO / MIND /
/ 2 min read / VIDEO
DEMONIC DEFIANCE

On Monday, September 22, 2025, President Trump announced on the evening news a reported link between autism and Tylenol use during pregnancy, urging pregnant women to stop using the drug immediately. Having previously pledged to investigate the rising autism rates in the United States, Trump and RFK Jr. presented this finding as both a political victory for fulfilling their promise and a critical public health announcement.

Yet, in an act of demonic defiance, some pregnant women have staged a sickening viral video campaign that exposes how far from God we’ve fallen. These women brazenly film themselves swallowing Tylenol, flaunting their pregnant bellies, and often mocking Trump with claims they trust “science” over him. Their refusal to separate their hatred for Trump from scientific evidence is nothing short of terrifying.


A systematic review in Environmental Health analyzed 46 studies on prenatal Tylenol exposure and autism. Of eight studies on autism spectrum disorder, five found significant links to maternal Tylenol use, with higher doses tied to greater risk. While causation isn’t proven, the consistent evidence prompted a call to limit Tylenol use in pregnancy under medical guidance—the very science these defiant women ignore while claiming to champion it.

George Alexopoulos
Evaluation of the evidence on acetaminophen use and neurodevelopmental disorders using the Navigation Guide methodology - Environmental Health
Background Acetaminophen is the most commonly used over-the-counter pain and fever medication taken during pregnancy, with > 50% of pregnant women using acetaminophen worldwide. Numerous well-designed studies have indicated that pregnant mothers exposed to acetaminophen have children diagnosed with neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD), at higher rates than children of pregnant mothers who were not exposed to acetaminophen. Methods We applied the Navigation Guide methodology to the scientific literature to comprehensively and objectively examine the association between prenatal acetaminophen exposure and NDDs and related symptomology in offspring. We conducted a systematic PubMed search through February 25, 2025, using predefined inclusion criteria and rated studies based on risk of bias and strength of evidence. Due to substantial heterogeneity, we opted for a qualitative synthesis, consistent with the Navigation Guide’s focus on environmental health evidence. Results We identified 46 studies for inclusion in our analysis. Of these, 27 studies reported positive associations (significant links to NDDs), 9 showed null associations (no significant link), and 4 indicated negative associations (protective effects). Higher-quality studies were more likely to show positive associations. Overall, the majority of the studies reported positive associations of prenatal acetaminophen use with ADHD, ASD, or NDDs in offspring, with risk-of-bias and strength-of-evidence ratings informing the overall synthesis. Conclusions Our analyses using the Navigation Guide thus support evidence consistent with an association between acetaminophen exposure during pregnancy and increased incidence of NDDs. Appropriate and immediate steps should be taken to advise pregnant women to limit acetaminophen consumption to protect their offspring’s neurodevelopment.
BioMed CentralDiddier Prada